Skip to main content

Advertisement

SpringerLink
Log in

Therapeutic approach to Lennox–Gastaut syndrome: a systematic review

  • Review article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

Lennox–Gastaut syndrome (LGS) is a rare, age-related syndrome, characterized by multiple seizure types, mental regression, and specific EEG abnormalities. It is one of the most challenging epilepsy: treatment is rarely effective and the final prognosis remains poor, despite the availability of several antiepileptic drugs, validated through well-designed, randomized, controlled trials. However, it is reasonable to consider non-medical treatments, such as surgery, after failure of two-to-three drugs. This review has as goal to describe systematically the different therapeutic options for LGS, including, not only recognized antiepileptic drugs, but also new oral drugs, immune therapy, diet, surgery, and neurostimulation techniques.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. van Rijckevorsel K (2008) Treatment of Lennox–Gastaut syndrome: overview and recent findings. Neuropsychiatr Dis Treat 4(6):1001–1019

    Article  PubMed  PubMed Central  Google Scholar 

  2. Arzimanoglou A et al (2009) Lennox–Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 8(1):82–93

    Article  PubMed  Google Scholar 

  3. Crumrine PK (2002) Lennox–Gastaut syndrome. J Child Neurol 17(Suppl 1):S70–S75

    Article  PubMed  Google Scholar 

  4. Vassella F et al (1978) Double-blind study on the anti-convulsive effect of phenobarbital and valproate in the Lennox syndrome. Schweiz Med Wochenschr 108(19):713–716

    CAS  PubMed  Google Scholar 

  5. Covanis A, Gupta AK, Jeavons PM (1982) Sodium valproate: monotherapy and polytherapy. Epilepsia 23(6):693–720

    Article  CAS  PubMed  Google Scholar 

  6. Motte J et al (1997) Lamotrigine for generalized seizures associated with the Lennox–Gastaut syndrome. Lamictal Lennox–Gastaut Study Group. N Engl J Med 337(25): 1807-1812

    Article  CAS  PubMed  Google Scholar 

  7. Sachdeo RC et al (1999) A double-blind, randomized trial of topiramate in Lennox–Gastaut syndrome. Topiramate YL Study Group. Neurology 52(9):1882–1887

    Article  CAS  PubMed  Google Scholar 

  8. Kim HJ et al (2014) Adjunctive levetiracetam treatment in pediatric Lennox–Gastaut syndrome. Pediatr Neurol 51(4):527–531

    Article  PubMed  Google Scholar 

  9. Conry JA et al (2014) Stable dosages of clobazam for Lennox–Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years. Epilepsia 55(4):558–567

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Isojarvi J et al (2016) Clobazam-treated patients with Lennox–Gastaut syndrome experienced fewer seizure-related injuries than placebo patients during trial OV-1012. Epilepsia 57(6):e113–e116

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Isojarvi J et al (2018) Optimizing clobazam treatment in patients with Lennox–Gastaut syndrome. Epilepsy Behav 78:149–154

    Article  PubMed  Google Scholar 

  12. Sankar R et al (2014) Clinical considerations in transitioning patients with epilepsy from clonazepam to clobazam: a case series. J Med Case Rep 8:429

    Article  PubMed  PubMed Central  Google Scholar 

  13. Vassella F et al (1973) Treatment of infantile spasms and Lennox–Gastaut syndrome with clonazepam (Rivotril). Epilepsia 14(2):165–175

    Article  CAS  PubMed  Google Scholar 

  14. Glauser T et al (2008) Rufinamide for generalized seizures associated with Lennox–Gastaut syndrome. Neurology 70(21):1950–1958

    Article  CAS  PubMed  Google Scholar 

  15. You SJ et al (2008) Clinical efficacy of zonisamide in Lennox–Gastaut syndrome: Korean multicentric experience. Brain Dev 30(4):287–290

    Article  PubMed  Google Scholar 

  16. Felbamate Study Group in Lennox–Gastaut, S (1993) Efficacy of felbamate in childhood epileptic encephalopathy (Lennox–Gastaut syndrome). N Engl J Med 328(1): 29–33

    Article  Google Scholar 

  17. Caraballo RH et al (2018) Sulthiame add-on therapy in children with Lennox–Gastaut syndrome: a study of 44 patients. Seizure 62:55–58

    Article  PubMed  Google Scholar 

  18. Devinsky O et al (2016) Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol 15(3):270–278

    Article  CAS  PubMed  Google Scholar 

  19. Geffrey AL et al (2015) Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy. Epilepsia 56(8):1246–1251

    Article  CAS  PubMed  Google Scholar 

  20. GW Pharmaceutical Announces Positive Phase 3 Pivotal Study Results for Epidiolex®(cannabidiol) in the Treatment of Lennox–Gastaut Syndrome (2016) GW Pharmaceuticals website. https://www.gwpharm.com/about/news/gw-pharmaceuticals-announces-positive-phase-3-pivotal-trial-results-epidiolex. Accessed 9 Nov 2016

  21. GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for Epidiolex®(cannabidiol) in the Treatment of Lennox–Gastaut Syndrome (2016) GW Pharmaceuticals website. http://ir.gwpharm.com/news-releases/news-release-details/gw-pharmaceuticals-announces-second-positive-phase-3-pivotal-0. Accessed 9 Nov 2016

  22. Grosso S et al (2014) Efficacy and tolerability of add-on lacosamide in children with Lennox–Gastaut syndrome. Acta Neurol Scand 129(6):420–424

    Article  CAS  PubMed  Google Scholar 

  23. Andrade-Machado R et al (2015) Efficacy and tolerability of add-on Lacosamide treatment in adults with Lennox–Gastaut syndrome: an observational study. Seizure 33:81–87

    Article  PubMed  Google Scholar 

  24. Miskin C et al (2016) Efficacy and tolerability of lacosamide in the treatment of children with refractory generalized epilepsy. J Child Neurol 31(7):925–928

    Article  PubMed  Google Scholar 

  25. Auvin S et al (2017) Use of perampanel in children and adolescents with Lennox–Gastaut Syndrome. Epilepsy Behav 74:59–63

    Article  PubMed  Google Scholar 

  26. Steinhoff BJ et al (2014) First clinical experiences with perampanel–the Kork experience in 74 patients. Epilepsia 55(Suppl 1):16–18

    Article  CAS  PubMed  Google Scholar 

  27. Huber B, Schmid G (2017) A two-year retrospective evaluation of perampanel in patients with highly drug-resistant epilepsy and cognitive impairment. Epilepsy Behav 66:74–79

    Article  PubMed  Google Scholar 

  28. Lagae L et al (2018) A pilot, open-label study of the effectiveness and tolerability of low-dose ZX008 (fenfluramine HCl) in Lennox–Gastaut syndrome. Epilepsia 59(10):1881–1888

    Article  CAS  PubMed  Google Scholar 

  29. Yamatogi Y et al (1979) Treatment of the Lennox syndrome with ACTH: a clinical and electroencephalographic study. Brain Dev 1(4):267–276

    Article  CAS  PubMed  Google Scholar 

  30. O'Regan ME, Brown JK (1998) Is ACTH a key to understanding anticonvulsant action? Dev Med Child Neurol 40(2):82–89

    Article  CAS  PubMed  Google Scholar 

  31. Sinclair DB (2003) Prednisone therapy in pediatric epilepsy. Pediatr Neurol 28(3):194–198

    Article  PubMed  Google Scholar 

  32. Gross-Tsur V et al (1993) Intravenous high-dose gammaglobulins for intractable childhood epilepsy. Acta Neurol Scand 88(3):204–209

    Article  CAS  PubMed  Google Scholar 

  33. Illum N et al (1990) Intravenous immunoglobulin: a single-blind trial in children with Lennox–Gastaut syndrome. Neuropediatrics 21(2):87–90

    Article  CAS  PubMed  Google Scholar 

  34. van Rijckevorsel-Harmant K, Delire M, Rucquoy-Ponsar M (1986) Treatment of idiopathic West and Lennox–Gastaut syndromes by intravenous administration of human polyvalent immunoglobulins. Eur Arch Psychiatry Neurol Sci 236(2):119–122

    Article  PubMed  Google Scholar 

  35. Caraballo RH et al (2014) Ketogenic diet in patients with Lennox–Gastaut syndrome. Seizure 23(9):751–755

    Article  PubMed  Google Scholar 

  36. Freeman JM et al (2009) A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia 50(2):322–325

    Article  PubMed  Google Scholar 

  37. Lemmon ME et al (2012) Efficacy of the ketogenic diet in Lennox–Gastaut syndrome: a retrospective review of one institution's experience and summary of the literature. Dev Med Child Neurol 54(5):464–468

    Article  PubMed  Google Scholar 

  38. Zhang Y et al (2016) Therapeutic effects of the ketogenic diet in children with Lennox–Gastaut syndrome. Epilepsy Res 128:176–180

    Article  PubMed  Google Scholar 

  39. Sharma S et al (2015) Use of the modified Atkins diet in Lennox Gastaut syndrome. J Child Neurol 30(5):576–579

    Article  PubMed  Google Scholar 

  40. Kossoff EH et al (2018) Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open 3(2):175–192

    Article  PubMed  PubMed Central  Google Scholar 

  41. Lee YJ et al (2010) Resective pediatric epilepsy surgery in Lennox–Gastaut syndrome. Pediatrics 125(1):e58–66

    Article  PubMed  Google Scholar 

  42. Liu SY et al (2012) Surgical treatment of patients with Lennox-Gastaut syndrome phenotype. Sci World J 2012:614263. https://doi.org/10.1100/2012/614263

    Article  Google Scholar 

  43. Rolston JD et al (2018) Multiple subpial transections for medically refractory epilepsy: a disaggregated review of patient-level data. Neurosurgery 82(5):613–620

    Article  PubMed  Google Scholar 

  44. Spencer SS et al (2002) Multiple subpial transection for intractable partial epilepsy: an international meta-analysis. Epilepsia 43(2):141–145

    Article  PubMed  Google Scholar 

  45. Cukiert A et al (2006) Extended, one-stage callosal section for treatment of refractory secondarily generalized epilepsy in patients with Lennox–Gastaut and Lennox-like syndromes. Epilepsia 47(2):371–374

    Article  PubMed  Google Scholar 

  46. Liang S et al (2014) Anterior corpus callosotomy in school-aged children with Lennox–Gastaut syndrome: a prospective study. Eur J Paediatr Neurol 18(6):670–676

    Article  PubMed  Google Scholar 

  47. Kwan SY et al (2000) Seizure outcome after corpus callosotomy: the Taiwan experience. Childs Nerv Syst 16(2):87–92

    Article  CAS  PubMed  Google Scholar 

  48. You SJ et al (2008) Comparison of corpus callosotomy and vagus nerve stimulation in children with Lennox–Gastaut syndrome. Brain Dev 30(3):195–199

    Article  PubMed  Google Scholar 

  49. Morris GL 3rd et al (2013) Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 81(16):1453–1459

    Article  PubMed  PubMed Central  Google Scholar 

  50. Cersosimo RO et al (2011) Vagus nerve stimulation: effectiveness and tolerability in 64 paediatric patients with refractory epilepsies. Epileptic Disord 13(4):382–388

    PubMed  Google Scholar 

  51. Cukiert A et al (2013) A prospective long-term study on the outcome after vagus nerve stimulation at maximally tolerated current intensity in a cohort of children with refractory secondary generalized epilepsy. Neuromodulation 16(6):551–556 (discussion 556)

    Article  PubMed  Google Scholar 

  52. Cukiert A et al (2013) Long-term outcome after callosotomy or vagus nerve stimulation in consecutive prospective cohorts of children with Lennox–Gastaut or Lennox-like syndrome and non-specific MRI findings. Seizure 22(5):396–400

    Article  PubMed  Google Scholar 

  53. Li MCH, Cook MJ (2018) Deep brain stimulation for drug-resistant epilepsy. Epilepsia 59(2):273–290

    Article  PubMed  Google Scholar 

  54. Fisher RS et al (1992) Placebo-controlled pilot study of centromedian thalamic stimulation in treatment of intractable seizures. Epilepsia 33(5):841–851

    Article  CAS  PubMed  Google Scholar 

  55. Velasco F et al (2000) Predictors in the treatment of difficult-to-control seizures by electrical stimulation of the centromedian thalamic nucleus. Neurosurgery 47(2):295–304 (discussion 304-5)

    Article  CAS  PubMed  Google Scholar 

  56. Son BC et al (2016) Clinical outcome of patients with deep brain stimulation of the centromedian thalamic nucleus for refractory epilepsy and location of the active contacts. Stereotact Funct Neurosurg 94(3):187–197

    Article  PubMed  Google Scholar 

  57. Auvichayapat N et al (2016) Transcranial direct current stimulation for treatment of childhood pharmacoresistant lennox–Gastaut syndrome: a pilot study. Front Neurol 7:66

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Av. Hippocrate 10, 1200, Brussels, Belgium

    Serena Borrelli

  2. Department of Neurology, Center for Refractory Epilepsy, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Av. Hippocrate 10, 1200, Brussels, Belgium

    Riem El Tahry

Authors
  1. Serena Borrelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Riem El Tahry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Serena Borrelli.

Ethics declarations

Conflict of interest

All the authors declare that they have no conflict of interest.

Ethical approval

This article does not include any studies on human or animal participants performed by the authors.

Informed consent

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Borrelli, S., El Tahry, R. Therapeutic approach to Lennox–Gastaut syndrome: a systematic review. Acta Neurol Belg 119, 315–324 (2019). https://doi.org/10.1007/s13760-019-01185-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-019-01185-5

Keywords

Search

Navigation